Metabolic Networks in KRAS-Driven Tumors: Tissue Specificity, Microenvironment & TROP2 Research

This article, 'Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment,' investigates the metabolic networks within tumors driven by mutant KRAS, focusing on tissue specificities and the role of the microenvironment. The authors, Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, and Costas A. Lyssiotis, explore the complex interplay between these factors.

Regarding renowned articles concerning TROP2, here are a few examples:

1. 'Targeting TROP2 in solid tumors: future prospects' by Zhi Yang et al. (2019) - This article delves into the potential of TROP2 as a therapeutic target across various solid tumors.

2. 'TROP2: A Promising Biomarker for Cancer Immunotherapy' by Qian Huang et al. (2020) - This article examines the significance of TROP2 as a biomarker for cancer immunotherapy and its potential applications.

3. 'TROP2 expression in extramammary Paget's disease: potential role as a novel therapeutic target' by Takayuki Nakamura et al. (2019) - This study explores the expression of TROP2 in extramammary Paget's disease and suggests its potential as a therapeutic target.

Concerning existing molecular pathways linked to TROP2, available information is limited. TROP2 is known to participate in various cellular processes, including cell proliferation, survival, and migration. However, specific molecular pathways associated with TROP2 are still under investigation. Further research is required to fully understand the complex network of molecular pathways involving TROP2.